Cellular therapy of corneal epithelial defect by adipose mesenchymal stem cell-derived epithelial progenitors.

CONCLUSION: Human ADSC-derived epithelial-like cells, via MET, recovered the CE from PED associated with LSCD. ADSC can be a viable adult stem cell source for potential autologous epithelial cell-based therapy for corneal surface disorders.
PMID: 31900226 [PubMed - in process]

Source: Cell Research - January 2, 2020 Category: Cytology Authors: Bandeira F, Goh TW, Setiawan M, Yam GH, Mehta JS Tags: Stem Cell Res Ther Source Type: research